Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Stiefel Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014335
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medications, over-the-counter products and signature products for the treatment of a range of dermatology conditions. It provides treatment of a variety of dermatological ailments such as acne, atopic dermatitis, psoriasis, eczema, soriatane, seborrheic dermatitis, and various forms of dermatoses. Stiefel Laboratories is headquartered in Raleigh, North Carolina, the US.

Stiefel Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Stiefel Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Stiefel Labs Acquires WBI-1001 From Welichem Biotech For US$34 Million 11
Asset Transactions 13
Almirall Acquires Rights to Veltin and Altabax from Stiefel 13
Aqua Pharma Acquires US Rights To Verdeso Foam From Stiefel 14
Merz Pharma Acquires Onmel From Stiefel Labs 15
Aqua Pharma Acquires XOLEGEL, Topical Treatment Of Seborrheic Dermatitis, From Stiefel Labs 16
Stiefel Laboratories Inc – Key Competitors 17
Stiefel Laboratories Inc – Key Employees 18
Stiefel Laboratories Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stiefel Laboratories Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Stiefel Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stiefel Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stiefel Labs Acquires WBI-1001 From Welichem Biotech For US$34 Million 11
Almirall Acquires Rights to Veltin and Altabax from Stiefel 13
Aqua Pharma Acquires US Rights To Verdeso Foam From Stiefel 14
Merz Pharma Acquires Onmel From Stiefel Labs 15
Aqua Pharma Acquires XOLEGEL, Topical Treatment Of Seborrheic Dermatitis, From Stiefel Labs 16
Stiefel Laboratories Inc, Key Competitors 17
Stiefel Laboratories Inc, Key Employees 18
Stiefel Laboratories Inc, Subsidiaries 19

★海外企業調査レポート[Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ocean Power Technologies Inc (OPTT):企業の財務・戦略的SWOT分析
    Ocean Power Technologies Inc (OPTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Nobility Homes Inc:企業の戦略的SWOT分析
    Nobility Homes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Transasia Bio-Medicals Ltd-医療機器分野:企業M&A・提携分析
    Summary Transasia Bio-Medicals Ltd (Transasia), a subsidiary of Erba Diagnostics Mannheim GmbH is an in-vitro diagnostic company that manufactures and exports diagnostic instruments and reagents. The company offers its products in various categories including clinical chemistry, immunology, diabetes …
  • MDNA Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Newcrest Mining Ltd:企業の戦略・SWOT・財務情報
    Newcrest Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Newcrest Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sims Metal Management Limited:戦略・SWOT・企業財務分析
    Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Michigan Public Power Agency:発電所・企業SWOT分析
    Michigan Public Power Agency - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Nichirei Corporation:企業の戦略・SWOT・財務情報
    Nichirei Corporation - Strategy, SWOT and Corporate Finance Report Summary Nichirei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nikkiso Co Ltd (6376):企業の製品パイプライン分析2018
    Summary Nikkiso Co., Ltd. (Nikkiso) is a diversified company that develops, manufactures and markets medical equipment and industrial instruments. The company’s product portfolio includes pumps, odorizing systems, metering and mixing systems, ceramic substrate production systems, water-conditioning …
  • One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • Bio-Gate Ag (BIG1):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Gate AG (Bio-Gate) is a medical technology company that develops, manufactures and markets antimicrobial products based on unique silver technologies. Its product portfolio includes antimicrobial plasma coating and additives, among others. The company also provides services such as produ …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • Kuwait Gulf Oil Co:企業の戦略的SWOT分析
    Kuwait Gulf Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Frequency Electronics Inc:企業の戦略・SWOT・財務分析
    Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report Summary Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Newrest Group International S.A.S:企業の戦略・SWOT・財務情報
    Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report Summary Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Oge Energy Corp:企業の戦略・SWOT・財務分析
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mercury Systems Inc (MRCY):企業の財務・戦略的SWOT分析
    Summary Mercury Systems Inc (Mercury) is a technology company that develops defense electronic solutions. It offers products such as chassis and subsystems, solid state drives, memory, mixed-signal processing, mission computing and avionics, system in package, high density secure memory, FPGA digita …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆